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 INTRODUCTION  
Brain granuloma is most common cause of seizures in young 
individuals in developing countries like India.. 
Neurocysticercosis and Tuberculoma are common etiology for 
the Brain granuloma .Cysticercosis, the infection caused by the 
larval stage of the tapeworm Taenia solium, is the most common 
parasitic disease of the nervous system in humans and the single 
most common cause of acquired epileptic seizures in the 
developing world. (1,3,4)   
 Mycobacterium Tuberculosis (TB), the organism historically 
responsible for “white plague and galloping consumption,” is 
still a major cause of morbidity and mortality across the world. 
The emergence of HIV, often in conjunction with intravenous 
(i.v.) drug use, has hampered efforts to control this 
microorganism and predisposed to the emergence of resistant .  
(12,44)
   
  
 Although important advances in the diagnosis, immunology, and 
pathophysiology of neurocysticercosis  and tuberculoma have 
been achieved in the past two decades, much of the natural 
history of the parasite infestation, its epidemiology, and clinical 
features remains uncertain. Disease may go undetected in 
patients or it may produce florid symptoms. (2,6)   
 
Despite its high frequency, the precise incidence and 
prevalence of NCC and Tuberculoma are difficult to obtain due 
to different factors, such as the high number of asymptomatic  
infections, the pleomorphism of clinical manifestations, the lack 
of a reliable test for serological screening, and the necessary use 
of expensive neuroimaging studies for diagnosis and therapeutic 
decisions. This study is intended to uncover the clinical and 
radiological features  of the brain granuloma. There by ,we can 
identify characteristics of the disease process in our setup. 
 
  
AIM OF THE STUDY 
 
1.  To study the etiologic profiles of patients with Brain granuloma .  
2.  To analyze the age and sex distribution, presenting history, clinical 
findings and investigations at admission in the study group. 
 
 
 
 
 
 
  
                 
 Review of Literature 
 
             NEUROCYSTICERCOSIS 
INTRODUCTION 
 The geographic distribution of cysticercosis is wide, with high 
prevalence reported from Mexico, Central and South America, India and 
Sub-Saharan Africa. One or several parasites may go undetected in the 
brain of a host throughout his or her lifetime; alternately, the parasites can 
trigger florid symptoms. NCC is the most common parasitic disease of 
the human nervous system. (1,4,5)   
  In India, the commonest form of NCC is the solitary parenchymal 
cyst. It is seen as a single, small (< 2 cm) enhancing lesion on the CT 
scans. This lesion commonly presents as simple partial or secondarily 
generalised seizures. In South India, single CT enhancing lesions  
(SCTEL) and NCC together accounted for 67% of provoking factors for 
acute symptomatic seizures.  (2)   
 
  Cysticercosis is a frequent infection in developing countries where 
pigs are raised . Population-based studies show substantially higher 
epilepsy rates in developing countries than in industrialized countries, a 
difference attributed in part to neurocysticercosis .Cysticercosis, the 
infection caused by the larval stage of the tapeworm Taenia solium, is the 
most common parasitic disease  of the nervous system in humans.  
 It is the single most common cause of acquired epileptic seizures in 
the developing world, where prevalence rates of active epilepsy are twice 
those in developed countries . (2,4)   
EPIDEMIOLOGY 
 
Its prevalence varies greatly according to the geographical region 
and is not yet precisely known. The increased ease of international travel, 
increasing number of migrants from developing countries and improved 
diagnostic techniques have led to widespread recognition of NCC as a 
common infection not only in developing countries, but also in developed 
countries.  
  In the pre-computerised tomography (CT) scan era, NCC as a 
cause of epilepsy in India was reported to vary from 2.2 to 9.6%.After the 
advent of CT and magnetic resonance imaging , NCC has been identified 
as the cause in 9 to 18.6% of patients with epilepsy. In a study from 
 Delhi, as high as 24% of 361 epileptic patients had unequivocal NCC on 
MRI. (2,14,23)   
 This  parasitic diseases are related to poverty, illiteracy, and 
deficient sanitary infrastructures. For these reasons, cysticercosis has 
been designated a “biologic marker” of the social and economic 
development of a community. (23)   
PATHOGENESIS 
LIFE CYCLE 
 The disease Taeniasis or pork tapeworm infection results from 
infestation of the small intestine by Taenia solium, the adult tapeworm. 
Humans are both the definitive and intermediate hosts for Taenia solium. 
Cysticercosis is a disease caused by the presence of Cysticercus 
cellulosae and Cysticercus racemose, the larval forms of Taenia solium in 
tissues. Humans can acquire the disease with either or sometimes with 
both. Cysticerci have a predilection for migrating to the central nervous 
system(CNS), eyes and striated muscle. The high glycogen or glucose 
content of these tissues may be responsible for such a tropism exhibited 
by cysticerci. When the CNS or eye is involved by cysticercosis, the 
patient has Neurocysticercosis (NCC). (23,28)   
  Cysticercosis is the larval tissue stage of the pork tapeworm, 
Taenia solium. When humans consume undercooked cysticercotic pork, 
the larva attaches to the gut wall and grows into the intestinal tapeworm. 
The life cycle is maintained when pigs eat human feces containing 
tapeworm eggs and develop porcine cysticercosis, a process facilitated by 
husbandry practices in  villages where pigs are free-roaming scavengers 
and human fecal contamination is widespread. These life-cycle stages are 
benign in comparison with those of human cysticercosis, defined  by the 
presence of T. solium larvae in human tissues, which occurs when people 
ingest tapeworm eggs from food, drink, or soil contaminated by the feces 
of a tapeworm carrier. (33,28)   
Seizures are the most common manifestation of symptomatic 
human cysticercosis . The disease may also be associated with headache, 
hydrocephalus, chronic meningitis, or symptoms due to a space-
occupying central nervous system (CNS) lesion . Isolated 
nonneurological manifestations, such as ocular or dermal cysts, account 
for 15% of cases of  
symptomatic disease . We therefore use the term neurocysticercosis 
interchangeably with the phrase symptomatic human cysticercosis. 
 
 
 LIFE CYCLE  
 
CHARACTERSITCS OF CYSTICERCI 
 
 Cysticerci are vesicles consisting of two main parts, the vesicle and 
the scolex. The vesicular wall is composed of three layers: an outer layer; 
a 
middle or cellular layer with pseudoepithelial structure, and an inner or 
reticular layer . The invaginated scolex has a structure similar to the adult 
cestode, with a rostellum armed with suckers and hooks, and a 
rudimentary body or strobila that includes the spiral canal. However, in 
some cysticerci the scolex cannot be identified. These parasites are 
composed of several membranes attached to each other that form clusters 
resembling a bunch of grapes. Because these cysticerci are usually 
 located within the subarachnoid space, it is believed that their scolex 
disappeared as the result of hydatoid degeneration. It is common practice 
to call cysts with scolex, Cysticercus cellulosae and those lacking the 
scolex, Cysticercus racemosus. 
  Macroscopic appearance of cysticerci varies according to their 
location. Cysticerci within the brain parenchyma usually measure around 
1 cm and tend to lodge in the cerebral cortex or basal ganglia . 
Subarachnoid cysticerci may also be small when they are located in the 
depth of cortical sulci between two cerebral convolutions. However, 
cysticerci within the sylvian fissure or CSF cisterns at the base of the 
skull may reach a size as large as 5 cm or more because their growth is 
not limited by the pressure of the brain parenchymal. Giant cysts usually 
lack the scolex due to the mechanism of hydatidiform degeneration 
previously described. Ventricular cysticerci are usually single and large, 
and may not have a scolex. They can attach to the choroid plexus or float 
freely in the ventricular cavity. The most common location of these cysts 
is the also fourth ventricle. Spinal cysticerci may be found at both the 
cord parenchyma and the subarachnoid space and their morphology is 
similar to cysticerci located within the brain. . (5,15,23)   
 
 
 
 PATHOLOGICAL CHANGES IN BRAIN 
 The inflammatory reaction around cysticerci usually induces 
multiple changes in the brain parenchyma, the meninges, the cerebral 
ventricles,and the spinal cord. The inflammatory reaction around 
parenchymal brain cysticerci is composed of lymphocytes, plasma cells, 
and eosinophils. It is usually associated with some degree of edema and 
reactive gliosis and varies according to the stage of cysticerci 
development . Meningeal cysticerci elicit an intense inflammatory 
reaction within the subarachnoid space. This causes thickening of the 
leptomeninges at the base of the skull. Chronic arachnoiditis and fibrosis 
produce deficits in the absorption of CSF. In addition, Luschka’s and 
Magendie’s foraminae may be occluded by thickened leptomeninges, 
with subsequent development of hydrocephalus . Blood vessels arising 
from the circle of Willis may also be affected. The walls of the small 
penetrating arteries are invaded by inflammatory cells, leading to 
proliferative endarteritis with occlusion of the lumen. This vascular 
involvement can result in the development of a cerebral infarct . 
 Ventricular cysticerci also elicit a local inflammatory reaction if 
they are attached to the choroid plexus or the ventricular wall. Ependymal 
cells proliferate and protrude toward the ventricular cavities, and may 
block the transit of CSF at the level of the cerebral aqueduct or Monro’s 
foraminae. This process is called granular ependymitis and is usually 
 associated with obstructive hydrocephalus. Cysticerci located in the 
spinal subarachnoid space may induce inflammatory and demyelinating 
changes in the ventral and dorsal roots of peripheral nerves in a similar 
way to cranial nerves. Likewise, inflammatory changes in the 
parenchyma of the spinal cord resemble those observed in the brain 
parenchyma. (23,15) 
 
 
 
 
Brain imaging demonstrating the four stages of parenchymal 
neurocysticercosis. A: Magnetic resonance imaging (MRI) of a vesicular 
cyst. Note the well-defined scolex, minimal contrast enhancement, and 
 mass effect. B: MRI of a colloidal cyst. Note ring enhancement, loss of 
the scolex, and perilesional edema. C: MRI of the nodular/granular 
stage. Note nodule with diffuse enhancement and no cystic component. 
D: Noncontrast   computed tomography showing multiple punctuate 
calcification. 
 
 
CLINICAL FEATURES 
 NCC indistinctly affects men and women from birth to senility, 
although it is more prevalent in middle-aged adults. Due to peculiarities 
of the immune response, it tends to be more severe in women than in 
men. It is a pleomorphic disease that may manifest a variety of unspecific 
clinical 
manifestations. This pleomorphism is related to individual differences in 
the number and location of lesions as well as to the extent of the host’s 
immune response to the parasite. Epilepsy, focal neurological deficits, 
increased intracranial pressure, and intellectual deterioration are the most 
common clinical manifestations of NCC, but are also observed in many 
other diseases of the nervous system. Therefore, in endemic areas this 
parasitic disease may mimic almost any neurological disorder.  (15,28,37)   
 
 Epilepsy 
 Epilepsy is the most common clinical manifestation of NCC and 
usually represents its primary manifestation .Indeed, NCC is the leading 
cause of adult-onset epilepsy in areas of the world where the disease is 
endemic . Seizures due to NCC are most commonly generalized tonic-
clonic or simple partial, although some patients may experience complex 
partial seizures, myoclonic seizures, or even specific epileptic syndromes. 
No clear correlation between number and location of brain cysticerci and 
electroencephalographic and clinical characteristics of the seizure. 
 
Focal neurological signs 
 A variety of focal neurological findings usually related to parasite 
size, number, and location are described in patients with NCC. Pyramidal 
tract signs predominate, but nearly every focal sign that may occur in 
nervous system disorders has been described in NCC, including vascular 
headache, sensory deficits, language disturbances, involuntary 
movements, parkinsonian rigidity, gait disturbances, and signs of 
brainstem dysfunction. 
 
 
 
 
 Stroke syndrome 
 Cerebrovascular complications of NCC include transient ischemic 
attacks, lacunar infarcts, large cerebral infarcts and rarely, subarachnoid 
hemorrhages . Lacunar infarcts are usually located in the posterior limb of 
the internal capsule or in the corona radiata, and produce typical lacunar 
syndromes such as pure motor hemiparesis and ataxic hemiparesis, 
clinically indistinguishable from those caused by atherosclerosis . While 
lacunar infarct was formerly considered the most common 
cerebrovascular complication of NCC, recent evidence suggests that 
largecerebral infarcts are more common. The cysticercal etiology of 
ischemic cerebral lesions should be considered in patients without risk 
factors for cerebrovascular disease, particularly in young adults with 
neuroimaging evidence of cystic lesions in the vicinity of the infarction 
area and evidence of inflammatory signs in the CSF analysis . 
Psychiatric disturbances` 
 Many patients with NCC present psychiatric manifestations or 
organic mental disorders ranging from poor performance on 
neuropsychological testing to dementia.   Psychotic episodes 
characterized by confusion, paranoid ideation, psychomotor agitation, 
violent behavior, and visual hallucinations have also been described in 
patients with parenchymal brain lesions. Severity of psychiatric 
manifestations correlated with presence of increased intracranial pressure 
 but not with number and location of parenchymal brain lesions or with 
coexistence of seizures. 
 
Intracranial hypertension 
 Patients with NCC present with increased intracranial pressure 
associated with seizures, focal neurological signs, or dementia. 
Hydrocephalus related to cysticercotic arachnoiditis, granular 
ependymitis, or ventricular cysts is the most common cause of this 
syndrome . In these cases, intracranial hypertension has a subacute onset 
and a slowly progressive course that may be punctuated by episodes of 
sudden loss of consciousness related to movements of the head (Bruns’ 
syndrome) when the cause of hydrocephalus is a fourth-ventricle cyst . 
Increased intracranial pressure also occurs in patients with giant cysts and 
in those with cysticercotic encephalitis. The latter is a particularly severe 
form of NCC that occurs as the result of a massive cysticerci infection of 
the brain parenchyma, inducing an intense immune response from the 
host. This condition is more frequent among children and young women, 
and is characterized by a clinical picture of subacute encephalitis 
associated with clouding of consciousness, seizures, diminution of visual 
acuity, headache, vomiting, and papilledema. Such cases resemble the 
pseudotumor cerebri syndrome except for the fact that CSF examination 
usually shows abnormalities that lead to diagnosis . 
  
Other manifestations 
 Intrasellar NCC presents with ophthalmologic and endocrinologic 
disturbances similar to those produced by pituitary tumors or 
craniopharyngiomas . Spinal arachnoiditis is characterized by root pain 
and weakness of subacute onset, and cysts in the cord parenchyma 
usually produce motor and sensory deficits that vary according to the 
level of the 
lesion . Intraocular cysticerci are most oftenlocated in the subretinal space 
and are the cause of a clinical picture characterized by progressive 
decrease of visual acuity or visual field defects . In addition, the presence 
of the cysts may induce vitritis, uveitis, and endophthalmitis. Massive 
cysticercal infection of the striated muscles occasionally produces a 
clinical picture of pseudohypertrophic myopathy with generalized 
weakness associated 
with painless and progressive muscle enlargement . (5,28)    
 
 
 
 
 DIAGNOSIS 
DIAGNOSTIC CRITERIA 
 Proposed Diagnostic  criteria for Human cysticercosis ,2001 
(Del Brutto et al) (1,37)   
Absolute 
Histologic demonstration of the parasite from biopsy of a brain or 
spinal cord lesion 
Cystic lesions showing the scolex on CT or MRI 
Direct visualization of subretinal parasites by fundoscopic examination 
 
Major 
Lesions highly suggestive of neurocysticercosis on neuroimagingstudies 
Positive serum immunoblot for the detection of anticysticercal antibodies 
Resolution of intracranial cystic lesions after therapy with albendazole 
or praziquantel 
Spontaneous resolution of small single enhancing lesions 
 
Minor 
Lesions compatible with neurocysticercosis on neuroimaging studies 
Clinical manifestations suggestive of neurocysticercosis 
Positive CSF ELISA for detection of anticysticercal antibodies or 
 cysticercal antigens 
Cysticercosis outside the central nervous system 
 
Epidemiologic 
Evidence of a household contact with T. solium infection 
Individuals coming from or living in an area where cysticercosis is 
endemic 
History of frequent travel to disease-endemic areas a CSF, cerebrospinal 
fluid; ELISA, enzyme-linked immunosorbent assay  
                      No diagnostic test identifies all cases of cysticercosis, and 
each test identifies a somewhat different group of individuals . 
SEROLOGY: 
EITB: 
 The current serological assay of choice for the diagnosis of 
neurocysticercosis is EITB; this assay has a specificity approaching 100 
% and a sensitivity of 94 to 98 % for patients with two or more cystic or 
enhancing lesions. A major weakness of this test is frequent false 
negative results in patients with a single intracranial cysticercus lesion, in 
whom fewer than 50 % test positive. The sensitivity and specificity of 
this test is also low in patients with calcified lesions. In a survey of 
patients who presented with seizures to emergency departments, several 
patients had positive EITB assays but without CT abnormalities or 
 exposure history suggestive of neurocysticercosis.  Access to EITB in 
India is limited 
 
ELISA : 
 In India, the ELISA test is extensively used for the diagnosis of 
cysticercosis. However, recent studies on serum have demonstrated a 
large number of false positive and false negative results. In contrast, 
ELISA using CSF was 87 % sensitive and 95 % specific and remains a 
useful supportive tool for the diagnosis. 
 
IMAGING: 
    Once the oncosphere has passed into the parenchyma, it grows and 
evolves through vesicular, colloidal, granular-nodular, and calcified 
phases. CT scans or MRIs can identify these four phases.  
 
VESICULAR PHASE: 
In the vesicular phase, the host tends to show immune tolerance. In most 
cases, there is no surrounding parenchymal reaction; the larva lives inside 
a translucent liquid-filled cystic structure surrounded by a thin membrane, 
where it can remain viable from a few months to several years . When the 
larva is viable, the CT scan-without enhancement by contrast media-
depicts circumscribed, rounded, hypodense areas, varying in size and 
 number. The average size of the cyst is 10 mm in diameter, but ranges 
from 4 to 20 mm. In the MRI, the vesicular larva appears with a 
cerebrospinal fluid (CSF)- like intensity signal on all sequences and no 
surrounding high signal on T,-weighted images . Both MRI and CT may 
show a high intensity, 2-4 mm mural nodule depicting the scolex in the 
interior of some parenchymal vesicular cysts . This picture has been 
named “hole-with eccentric dot imaging”  or “starry night effect”  and 
could be considered pathognomonic of cysticercosis; this phase 
corresponds to the active parenchymal form of 
the proposed classification of NC . Two pathologic changes take place 
when the host immune system reacts against the parasite . 
COLLOIDAL PHASE: 
  First  in the colloidal phase, the parasite begins to show 
degenerative changes, the vesicular fluid takes on a gelatinous colloidal 
aspect, and the wall thickens . In this phase, the contrast-enhanced CT 
scan shows an annular enhancement surrounded by irregular perilesional 
edema. The fluid content gives slightly higher signal than CSF and is 
sometimes isodense with the parenchyma on T, - or proton 
densityweighted images or both, and gives high signal on T,- weighted 
images . The capsule shows higher signal than the adjacent brain with 
thick ring enhancement on T, -weighted images, whereas on T,-weighted 
 images, there is a low ring signal surrounded by high-signal lesion, due 
mostly to edema .  
NODULAR-GRANULAR PHASE: 
                     The second pathologic change that takes place occurs in the 
nodular-granular phase. The vesicle tends to shrink, its content becoming 
semisolid as it is progressively replaced by granulomatous tissue. By 
using noncontrasted CT scan, these findings could correspond to a diffuse 
hypodense area with irregular borders. 
After the administration of contrast media, a small, hyperdense, rounded, 
nodular image surrounded by edema is observed . In this stage, T,-
weighted images are the most striking, as they show the change in the 
signal from the cyst fluid. The nodular isointense or low signal seen in 
some lesions is probably the result of early mineralization of the 
cystassociated with hyaline degeneration . The low signal probably 
represents the marginal mineralized scolex inside the residual cyst, which 
will show as a bulls-eye on CT (58). In these two consecutive phases, the 
parasite shows a progressive decay;)..  
 
CALCIFICATION:  
Finally, when the parasite dies, a mineralization and resorption process 
occurs, ending in a calcified nodule that lodges permanently in the CNS . 
The noncontrasted CT shows a rounded, homogeneous hyperdense 
 area, showing no enhancement of the contrast media. In the MRI, only 
the proton density-weighted image shows a low-intensity lesion . This 
phase corresponds to the inactive parenchymal form of the proposed 
classifications of NCC. 
 VARIANT : 
One form of NCC that has different clinical and radiologic characteristics 
from those described is the so-called ‘‘cysticercotic encephalitis” that 
occurs mainly in children and young women . The noncontrast CT image 
shows diffuse and intense cerebral edema and small or collapsed 
ventricles; with contrast media, multiple, small, hyperdense, nodular, or 
annular images appear disseminated throughout the whole cerebral 
parenchyma . Being immersed in a CSF-rich environment, these 
cysticerci can evolve into the racemose form of NCC . These types of 
cysts are most frequently located either in the basal cisterns or inside the 
sylvian valley and can reach 100 mm in diameter . The noncontrasted CT 
depicts a hypodense image in the subarachnoid or ventricular space; the 
cysts deform the surrounding structures, and noncommunicating 
hydrocephalus occurs . The MRI (proton or T,- weighted) more precisely 
shows the cyst as a hypointense CSF-like image in all phases; it permits a 
direct visualization of intraventricular cysticercosis by identifying the 
cyst wall, scolex, or both . The ventricular ependymal lining reacts to the 
cysts, causing an inflammatory reaction or ependymitis, which can be 
 visualized by CT or MRI as a high-intensity signal in the ependymal 
layer. Gadolinium-enhanced MRI is more sensitive than contrast-
enhanced CT to detect ependymitis 
 ‘ 
TUBERCULOMA VS NEUROCYSTICERCOSIS. (27)   
Rajshekhar et al made an attempt to differentiate between these two 
entities on the basis of clinical and imaging features and subsequently, on 
the basis of this study and their experience Rajshekhar and Chandy noted 
that cysticerci are usually round in shape, 20 mm or less in size with ring 
enhancement or visible scolex, and cerebral edema severe enough to 
produce midline shift or focal neurological deficit is not seen. 
Tuberculomas are usually irregular, solid and greater than 20 mm in size. 
They are often associated with severe perifocal edema and focal 
neurological deficit 12 . No histopathological study has ever 
demonstrated that all large lesions (>20 mm) are tuberculomas and 
nothing else.  
                        On the contrary, every retrospective and prospective 
follow-up study of single enhancing CT lesions in patients with new-
onset seizures observed the spontaneous resolution of the lesions 
irrespective of their size, shape and amount of surrounding edema. 
Another important point is that, in none of these series worsening 
(enlargement of CT lesion and appearance of new symptoms or focal 
 deficit) has been noted though such a fear has always been expressed.In 
fact, several series which included patients with CT lesions of varied 
sizes, shapes and perifocal edema, identical favorable clinical and 
radiological courses were obtained. 
                                 
  MRI VS CT IMAGING  
               MRI is more sensitive than CT scans for the diagnosis of NCC 
since it improves recognition of the perilesional edema and degenerative 
changes of the parasite, as well as small cysts or those located inside the 
ventricles, brain stem, cerebellum and the racemose vesicles at the level 
of the posterior fossae and basal cisterns. However, CT scans are more 
sensitive for the detection of calcifications. 
EEG: 
 There is a poor correlation between seizure type and EEG findings 
in patients with epilepsy due to neurocysticercosis. The EEGs are normal 
in more than 50% of these patients and when present EEG abnormalities 
correlate  poorly with the clinical characteristics of the seizures or with 
the location of parasites within the brain parenchyma. It is quiet common 
to have generalized abnormalities in patients with a single parenchyma 
cyst and focal paroxysmal activity in patients with disseminated infection. 
The two possible explanations for this phenomenon  are 1.some cerebral 
areas are resistant to epileptogenic effects of cysticerci, and  2. the 
 parasite may generate local epileptogenic activity and activate distant 
sites by cortical or subcortical spread. (33,14)   
 
MANAGEMENT 
 Characterization of the disease in terms of cyst viability, degree of 
host immune response to parasites, and lesion location is of major 
importance for rational therapy, which includes a combination of 
symptomatic therapy (e.g., antiepileptic drugs), specific cysticidal drugs, 
steroid antiinflammatory therapy, surgical resection of lesions, and 
placement of ventricular shunts. 
 
Cysticidal drugs 
 Praziquantel is an isoquinoline with proven cysticidal properties 
used to treat human NCC since 1979 . Subsequent studies show that 
praziquantel eliminates up to 70% of parenchymal brain cysticerci after a 
15-day course of treatment at daily doses of 50 mg/kg. Albendazole is an 
imidazole that also has cysticidal properties.This drug was initially 
administered at doses of 15 mg/kg/ day during 1 month .  
 Nevertheless, additional studies showed that at similar doses, 
length of therapy could be shortened to 1 week without lessening the 
efficacy of the drug . Albendazole destroys 75–90% of parenchymal brain 
 cysts and has been superior to praziquantel in several trials comparing the 
efficacy of both drugs . 
 Another advantage of albendazole over praziquantel is that the 
former also destroys subarachnoid and ventricular cysts, due to its better 
penetration of CSF .Recommended regimen  of praziquantel have ranged 
from 10–100 mg/kg for periods of 3–21 days . In these studies, 
praziquantel was administered every 8 h..The percentage of cyst 
disappearance in neuroimaging studies was similar to that observed in 
patients receiving longer courses of the drug at conventional doses . 
 
Albendazole (ABZ) is considered the medication of choice for the 
antiparasitic therapy of NCC, in a regimen of 15 mg/kg/day divided into 
two doses every 12 h for 8 days.Its main use is for symptomatic patients 
showing multiple viable brain parenchymal cysticerci. The viability of 
cysticerci is characterized by the presence of rounded areas of hypodense 
lesions seen on CT with a scolex inside the cyst, better shown on MRI, 
without contrast enhancement or surrounding edema. 
 
Symptomatic therapy 
Antiepileptics 
 Most patients with NCC present with seizures and the 
administration of standard doses of single first-line antiepileptic drugs, 
 such as phenytoin or carbamazepine, usually results in adequate seizure 
control. Patients with parenchymal brain cysts must be treated with 
anticysticercal drugs to eliminate infection, prevent development of a 
granuloma, and achieve adequate control of seizures with antiepileptic 
drugs. The optimal length of antiepileptic drug therapy in patients with 
NCC has not been settled. A recent prospective study showed that up to 
50% of these patients had relapses after withdrawal of antiepileptic drugs 
. These patients had been free of seizures for 2 years, and their 
parenchymal brain cysts had been successfully destroyed with 
albendazole. Prognostic factors associated with seizure recurrence include 
secondary development of parenchymal granulomas or calcifications and 
the presence of both recurrent seizures and multiple brain cysts before 
institution of cysticidal therapy.  
 
Steroids 
 Corticosteroids are frequently used in patients with NCC, and 
represent the primary form of therapy for cysticercotic encephalitis, 
angiitis, and arachnoiditis causing hydrocephalus and progressive 
entrapment of cranial nerves . In patients with cysticercotic encephalitis, 
corticosteroids may be used alone or in association with mannitol at doses 
of 2 mg/kg/day . In these cases, the initial trial with high doses of 
intravenous dexamethasone may be followed by chronic oral therapy with 
 prednisone (50 mg) or dexamethasone (10 mg) 3 days a week 
.Association with dexamethasone has been recommended to ameliorate 
the secondary effects of headache and vomiting that may occur during the 
first 2 days of praziquantel or albendazole therapy.These manifestations 
are not related to the toxic effects of cysticidal therapy but rather to the 
acute destruction of parasites within the brain, and are reliable indicators 
of drug efficacyAbsolute indications for corticosteroid administration 
during cysticidal drug therapy include management of patients with giant 
subarachnoid cysticerci, ventricular cysts, spinal cysts, and multiple 
parenchymal brain cysts. In these cases, corticosteroids mustbe 
administered before, during, and even some days after the course of 
anticysticercal drugs to avoid the risk of cerebral infarcts, acute 
hydrocephalus, spinal cord swelling, and massive brain edema, 
respectively . 
 The goal of anticysticercal therapy is the simultaneous destruction 
of multiple cysts then controlling the resulting inflammatory reaction 
with steroids. . (33,14,23,25)  
 
 
 
 
  
 
Guidelines for use of antiparasitic treatment in neurocysticercosis. (1)   
Type 
Infection 
burden Recommendations Evidence 
 
Parenchymal 
neurocysticercosis 
   
    Viable (live cysts) Mild (1 to 5 
cysts) 
(a) Antiparasitic 
treatment, with steroids 
II-3 
  (b) Antiparasitic 
treatment; steroids used 
only if side effects 
related to therapy appear 
II-3 
  (c) No antiparasitic 
treatment; neuroimaging 
follow-up 
II-3 
 Moderate 
(more than 5 
Consensus: antiparasitic 
treatment with steroids 
II-3 
 (more than 5 
cysts) 
treatment with steroids 
 Heavy (more 
than 100 cysts) 
(a) Antiparasitic 
treatment with high-dose 
steroids 
III 
  (b) Chronic steroid 
management; no 
antiparasitic treatment; 
neuroimaging follow-up 
III 
    Enhancing lesions 
(degenerating cysts) 
Mild or 
moderate 
(a) No antiparasitic 
treatment; neuroimaging 
follow-up 
I 
  (b) Antiparasitic 
treatment with steroids 
II-3 
  (c) Antiparasitic 
treatment; steroids only 
if side effects develop 
II-3 
 Heavy 
(cysticercotic 
encephalitis) 
Consensus: no 
antiparasitic treatment; 
high-dose steroids and 
III 
 encephalitis) high-dose steroids and 
osmotic diuretics 
    Calcified cysticerci Any number Consensus: no 
antiparasitic treatment 
 
    
Extraparenchymal 
neurocysticercosis 
   
    Ventricular 
cysticercosis 
 Consensus: 
neuroendoscopic 
removal, when available. 
If not available: 
III 
  (a) CSF diversion 
followed by antiparasitic 
treatment, with steroids 
III 
  (b) open surgery (mainly 
for ventricle cysts) 
III 
    Subarachnoid cysts, 
including giant cysts or 
racemose cysticercosis, 
and chronic meningitis 
 Consensus: antiparasitic 
treatment with steroids, 
ventricular shunt if there 
is hydrocephalus 
II-3 
 and chronic meningitis is hydrocephalus 
    Hydrocephalus with 
no visible cysts on 
neuroimaging 
 Consensus: ventricular 
shunt; no antiparasitic 
treatment 
III 
    
Spinal cysticercosis, 
intra- or extramedullaryb 
 Consensus: primarily 
surgical; anecdotal 
reports of successful use 
of albendazole with 
steroids 
III 
Ophthalmic 
cysticercosisb 
 Consensus: surgical 
resection of cystsc 
II-3 
 
a
 Levels of recommendations (a, b, and c) and quality of evidence  are 
defined in the text. 
b
 Given the rarity of these presentations, treatment was discussed based 
on the published literature . 
c
 Experience in the use of albendazole with methylprednisolone for 
treatment of retinal cysticercosis and as a presurgical treatment for 
intravitreal cysticercosis has been published  but not yet replicated. 
  
 Arguments in favor of and against antiparasitic treatment for 
neurocysticercosis 
Argument Reply 
 
 
Protreatment  
    Rapid disappearance of cysts No evidence that faster 
disappearance of cysts will 
result in better epilepsy control 
    Severe cases seen less frequently 
now 
Less severe cases reflect 
improved sanitation and fewer 
massive infections 
    Series of albendazole- or 
praziquantel-treated patients have 
better evolution (fewer seizures) 
than untreated patients seen at the 
same centers 
Inadequate "control" groups in 
initial studies 
    Fewer residual calcifications No evidence that antiparasitic 
therapy results in fewer 
 therapy results in fewer 
calcifications 
  
Antitreatment  
    Neurocysticercosis becomes 
symptomatic after a period of years 
as a result of onset of the process of 
parasite death 
Questionable methodology of 
"controlled" studies; some 
patients persist with symptoms 
and live cysts for years 
    Antiparasitic treatment leads to 
acute cerebral inflammation and is 
severe and unnecessary 
Inflammation can be controlled 
with steroids; chronic, moderate 
inflammation may lead to scars 
similar or worse than those from 
a short, acute, severe process 
    Reactions to treatment may lead 
to the death of the patient 
Less than 10 deaths reported 
(mainly massive infections) 
among many albendazole or 
praziquantel-treated cases 
 
 
 
 
  
 
Surgery 
 
 Prior to the advent of antiparasitic drugs, surgery was the primary 
therapy for neurocysticercosis, mainly open surgery for excision of large 
cysts or cysts in the ventricles. The role of surgical therapy in the 
management of neurocysticercosis has significantly decreased over time 
and is now mainlyrestricted to placement of ventricular shunts for 
hydrocephalus secondary to neurocysticercosis. The main problem in 
these cases is the high prevalence of shunt dysfunction; indeed, it is 
common for patients with hydrocephalus secondary to neurocysticercosis 
to have two or three shunt revisions.The protracted clinical course of 
these patients and their high mortality rates (up to 50% in two years) were 
directly related to the number of surgical interventions to change the 
shunt. 
           Many authors advocate shunting combined with antiparasitic drugs 
to further reduce the incidence of shunt failure . Recently, less invasive 
procedures have been described, specifically the use of  neuroendoscopic 
resection for ventricular cysts. Overall results have been excellent, with 
much less morbidity than with open surgery. . (25,33)   
PROGNOSIS 
 
  In , adults  first seen with new onset seizures and active cyst 
recurrences rates at 4 years are as high as 49%. After a second seizures , 
the estimated risk of the recurrence is 68% at 6 years . Prognosis is best 
for those patients in whom imaging studies normalize. 
 The recurrence rate for those patients with persisting , active cyst is more 
than double the rate of patients with normal imaging. Seizures 
recurrences and reduced in patients who initially have calcifications 
rather than active cyst. (37,25)   
 
                  TUBERCULOMA                   
INTRODUCTION:  
 Mycobacterium tuberculosis is an aerobic nonmotile bacteria 
characterized by slow growth . The frequency of CNS involvement of 
tuberculosis ranges from 0.5% to 5.0% in the literature and is seen most 
commonly in the developing countries.  The most frequent manifestation 
of CNS tuberculosis is tuberculous meningitis, followed by tuberculoma 
and tuberculous abcesses. Tuberculoma is encountered in only 15% to 
30% cases of CNS tuberculosis and are mostly hemispheric.   
 In the early 20th century, central nervous system (CNS) 
tuberculoma constituted 34% of all intracranial mass lesions identified at 
 autopsy.This ratio was found to be 0.2% in all biopsied brain tumours 
between the years 1955 and 1980 at a neurological institute in a 
developed country. Although large series from developing countries 
continue to be reported and incidence has increased for the last 20 years 
due to human immunodeficiency virus (HIV) infection and drug-resistant 
microorganisms. . (27,44,12)   
EPIDEMIOLOGY 
 Tuberculosis, an ancient disease, continues even today to be a 
major public health concern in many parts of the world. An estimated 1.7 
billion persons, one-third of the world’s population, are infected. This 
reservoir of infected persons results in 8 million cases of active 
tuberculosis and 2.9 million deaths annually. Disease’s manifests in both 
genders, with a  3:2 male/female rate and, with a greater frequency with 
the age ranging between the 2nd and 3rd decades. It reaches young adults 
and it is less common among children. This affection negative impact 
becomes evident for the most assailed subgroups, either from the 
occupational or from the educational point of view. 
   It has had a recent resurgence consequent to the emergence of 
AIDS in epidemic propor Intracranial tuberculomas develop in 
approximately 1% of all patients with active tuberculosis   and 4·5–28% 
 of those with tuberculous meningitis, but they may develop without any 
evidence of active disease. (31,34,12)   
 Intracranial tuberculomas constitute the most common intracranial 
mass lesions in neurotuberculosis, accounting for 5–11% of all 
intracranial space occupying lesions . Most often these lesions are 
diagnosed on the basis of neuroimaging studies and ATT is administered 
on a presumptive basis . 
PATHOGENESIS  
 It is believed that TB of the CNS, like any other forms of TB, 
begins with inhalation of aerosolized droplet nuclei, each containing a 
few tubercle bacilli. They reach the alveoli, where they multiply in 
alveolar spaces or in alveolar macrophages, and in macrophages derived 
from the circulation. 
During the first three weeks, virtually no immune response occurs; 
tubercle bacilli are disseminated hematogenously to extra-pulmonary 
sites, including the CNS. Mycobacteria are filtered from the blood by 
lungs, liver, spleen, and bone marrow, while they get trapped in organs 
like brain where there is no reticuloendothelial system. Following 
infection, because of the cell-mediated immune response, tubercle bacilli 
may get killed intracellularly within activated macrophages. Tubercles, 
 consisting of mononuclear cells surrounding a necrotic caseous center, 
are formed in the lungs as well as 
in secondary sites. The fate of these tubercles and the subsequent course 
of infection are functions of both the immunologic capacity of the host 
and poorly understood genetic factors. In the absence of effective host 
cell-mediated immunity, tubercles continue to grow, bacilli multiply, the 
caseous center liquefies, and finally the tubercles rupture. As a result, 
bacilli and their antigenically potent products are released into the 
surrounding tissues. If this progression occurs in the brain and meninges, 
different forms 
of cerebral TB can develop .  
  Cerebral TB develops in two stages. Initially, small intracerebral 
tuberculous lesions called “Rich Foci” develop in the CNS, either during 
the stage of bacteremia of the primary TB infection or shortly afterwards. 
These initial tuberculous lesions may be in the subpial or subependymal 
surface of the brain or the spinal cord may become active after several 
years of initial 
infection. Later these small tuberculous lesions located on the surface of 
the brain or the ependyma will rupture into the subarachnoid space or the 
ventricular region to cause meningitis. Those deep within the brain or 
spinal 
 cord parenchyma will enlarge to form tuberculoma or tuberculous abscess 
. Although the specific stimulus for the rupture or growth of Rich foci is 
not known, immunological mechanisms are believed to play an important 
role. 
The tuberculoma may also originate in the meninges, and may be found 
in the superficial cortex. The meningeal form may resemble a 
meningioma.  
Findings of systemic infection and many of the usual laboratory 
correlates of infection may be absent because tuberculous bacilli are not 
always evident in the CSF and even in the excised mass. Therefore, 
negative results from the bacterial examination do not eliminate the 
possibility of tuberculous infection. (36,39)   
 Tuberculomas are avascular, spherical granulamatous masses of 
small tubercles. A tubercle consists of a central core of epithelioid cells 
surrounded by lymphocytes and Langerhans giant cells. The inside of 
these masses contain necrotic areas composed of caseous material, 
occasionally thick and purulent, in which TB bacilli could be 
demonstrated. Tuberculomas are predominant in infratentorial regions in 
children, whereas they are observed in supratentorial regions in adults . 
Tuberculomas in sellar and pineal regions mimicking brain tumors are 
seen occasionally. 
  Tuberculoma en-plaque, an uncommon manifestation of 
tuberculoma, develops from the enlargement of one or more meningeal 
tubercles, leading to a distinctive, flat, adherent mass . It is considered to 
be a likely source of diffuse meningitis and is the result of bacillemia that 
occurs during the development of a primary lesion or after progressive 
infection . Paradoxical enlargement or development of tuberculomas 
during antituberculous treatment can occur . (36,39)   
CLINICAL FEATURES : 
 Tuberculoma of the brain equally affects men and women at any 
age, although children are more prone to this affliction in developing 
countries. In light of the non-specific common presentation, which is 
usually subacuteat onset, any infectious or tumoral processes can be 
evoked. Any personal history of tuberculosis, past or present, is of course 
highly contributive for the diagnosis, as is the overall general physical 
examination. Intracranial hypertension is noted in 72 to 75% of the cases 
and requires surgical ventriculo-peritoneal derivation in 12.5%, and 
papilloedema is seen in 42 to 93% . Seizures and focal epilepsy are 
reported in 42 to 85% of the cases, hemiparesis in 19 to 38%, isolated 
cranial nerve palsy in 12%, poor general health in 15% and fever in only 
10 to 25% . Other neurological symptoms attributable to the location of 
the lesion may be seen. HIV patients  have seizures less frequently (38%) 
 but fever is almost a constant finding, with a reported frequency of 76% 
in one study . They also are commonly confused at presentation (52% of 
the cases) and have a previous or active extracerebral tuberculosis in 66% 
of the cases . . (31,34)   
  The diagnosis is difficult because an active tuberculous infection 
of other organs is frequently not, or no longer, apparent.  Depending on 
their size and location, intracranial tuberculomas can have many signs 
mimicking primary central nervous system tumors, such as high 
intracranial pressure, focal neurologic deficits, and seizures.  
SYMPTOMS  
                          -seizures (60 to 100%) 
                          - Head ache (56- 93%) 
                          - focal neurological deficits (33-68%).  
Tuberculomas are usually solitary lesions, but they can be multiple in 15–
34% of cases. 
 
DIAGNOSIS 
IMAGING  
 On CT scan, tuberculomas are defined as low- or high-density, 
rounded or lobulated masses with irregular walls of varying thickness that 
 show homogeneous or ring enhancement after the contrast administration. 
Moderate to marked perilesional edema has been observed frequently. 
Tuberculomas may be single or multiple  and are common in the frontal 
and parietal lobes in parasagittal areas. A central calcification surrounded 
by a hypodense area with peripheral ring enhancement, called the “target 
sign”, is considered as characteristic of tuberculoma.  
 Based on CT images, tuberculomas are classifyed into immature 
forms, consisting of small discs and rings with a massive edema, and 
mature forms, appearingas large rings or lobulated masses . 
Neuroradiological imaging with CT and MR imaging are highly sensitive 
for tuberculoma, but their specificity for a definite diagnosis is low . 
 Although tuberculoma appears avascular when studied 
angiographically, its appearance on computerised tomographic (CT) scan 
and MRI varies. It is consistent with the evolving granulomatous nature 
of the disease. During the initial phase of the disease, oedema and 
necrosis may appear as a low attenuating area on CT scan. Once the 
granuloma has begun to organize, there may be high attenuation, contrast 
enhancement and calcification, as well as ring enhancement and a 
variable degree of surrounding oedema. The enhancement may be 
homogenous or there may be a central radiolucent area corresponding o 
the central zone of necrosis. 
  MRI is considered to be more sensitive than CT in detecting 
tuberculomas of the cerebral parenchyma. Tuberculoma are isointense 
with grey matter on Tl-weighted MR images. On T2- weighted images, 
lesions show central hyperintensity. .In some cases, a hypointense ring is 
present within the wall of the tuberculoma on T2 weighted images. Most 
tuberculomas are further outlined by a collar of high signal, resulting 
from oedema, on T2-weighted images. Tuberculomas, typically, 
“enhance” after the intravenous administration of gadopentetate 
dimeglumine in a solid or ring pattern. 
 MRI is more sensitive than CT in diagnosing central nervous 
system tuberculomas, especially for tuberculomas in the posterior fossa. 
Biopsy remains the gold standard for diagnosing intracranial 
tuberculomas; no imaging study can reliably rule out other causes of 
intracranial brain lesions. Stereotactic brain biopsy is preferred over 
craniotomy because of the reduced surgical risk. . (26,28,12,7)  
Other Investigations:  
In cases of intracranial tuberculomas and tubercular abscesses, 
the CSF analyses are unremarkable or show a mild, nonspecific increased 
protein content and usually negative bacteriology . The “gold standard” 
remains histologic. Approximately 60% of tissue specimens from 
tuberculomas show AFB in smear and culture. in most cases; often only 
 the CSF protein level is raised. Cultures for Myobacterium tuberculosis 
of CSF are rarely positive .  
The polymerase chain reaction of CSF,  appears to be  the  
sensitive diagnostic tool, with a reported sensitivity of 75%. 
  Laboratory tests, such as differential cell counts of blood 
leukocytes and erythrocyte sedimentation rate, can be  normal. Hints with 
regard to the differential diagnosis of an intracranial space-occupying 
lesion for a tuberculous focus are a positive tuberculin skin test (25-75%), 
signs of an active or healed pulmonary tuberculosis on chest radiograph 
(25-50%), relapsing cough, and the appearance of the lesion on cranial 
computed tomography or MRI. (12,7,26)   
 
 
MANAGEMENT 
  Before the introduction of antituberculous therapy the only 
treatment available for intracranial tuberculomas was surgery, which was 
associated with high mortality and postoperative meningitis. The general 
operative mortality was 10%, and the mortality from subsequent 
meningitis was an additional 40%. In more radical operations, mortality 
from surgery and postoperative meningitis approached 85%, with 
 mortality as high as 100% for posterior fossa tuberculomas. With the 
observation that streptomycin is effective in treating tuberculosis, 
mortality rates for tuberculoma excision decreased dramatically. 
 
MEDICAL MANAGEMENT : 
 
 The treatment of cerebral TB, like that of other forms of TB, is 
aimed at killing both intracellular and extracellular organisms and in 
preventing the development of drug resistance by using several drugs in 
combination. Early diagnosis, clinical staging of patients at the time of 
presentation, and the institution of prompt anti-tubercular treatment 
(ATT) are important factors in determining the outcome of cerebral TB. 
 Currently there is no general consensus on the number of drugs to be 
used and their optimal duration. However, based on their efficacy and 
toxicity, anti-tubercular drugs have been classified into first-line and 
second-line agents . The first line of antitubercular drugs , namely 
isoniazid, rifampicin, and pyrazinamide, penetrate well into the CSF . In 
inflamed meninges, the CSF concentrations of these drugs is at least 
equal to or higher than those in non-inflamed meninges. Isoniazid, 
pyrazinamide, ethionamide, and cycloserine penetrate into the CSF well 
in both inflamed and non-inflamed meninges. Rifampicin penetrates less 
 well . Rifampicin, streptomycin,and ethambutol penetrate in adequate 
concentrations only when the meninges is inflamed .  (31,10,16,22,26)   
Treatment regimen 
 There have been no randomised controlled trails to evaluate which 
antituberculous regimens are most effective in treating intracranial 
tuberculomas.The recommended initial therapy is isoniazid, rifampicin, 
ethambutol, and pyrazinamide, unless exposure to a multidrug-resistant 
pathogen is suspected. If the organism is sensitive, three-drug therapy 
with isoniazid, rifampicin,Ethambutol and pyrazinamide is given for 2 
months. Pyrazinamide and Ethambutol is then stopped, and isoniazid and 
rifampicin are continued until the completion of treatment.  
ANTI TUBERCULOUS THERAPY : 
  
 Recommended duration of therapy is 12 months in uncomplicated cases 
of cerebral TB, prolonged to 18 months if PZA is omitted or not 
tolerated. 
Tuberculomas usually decrease in size and resolve completely within 2–3 
months of instituting ATT, though sometimes it takes longer, even years, 
to resolve or leave a residual calcification . (16,22,26)   
 
 
ROLE OF CORTICOSTEROIDS : 
  Corticosteroids are administered early in the course of treatment, 
its morbidity and complications may be reduced . In a  trial, Schoeman et 
al. assessed the efficacy of CS and observed that, in addition to survival, 
it significantly improved the intellectual outcome and enhanced 
resolution of basal exudates and intracranial tuberculoma as shown by 
serial CT scans. Although studies have attempted to control paradoxical 
growth of the cerebral mass lesion or cerebral edema, the effect of 
steroids to suppress the paradoxical response is not clear.  
 Possible indications for the administration of corticosteroids in TB 
of the CNS are raised intracranial pressure, cerebral edema, focal 
neurological signs, hydrocephalus, infarcts, and basal optico-chiasmatic 
pachymeningitis. Now, most authorities to recommend medical 
management as the preferred treatment for intracranial tuberculomas, 
reserving surgical intervention for patients who require decompression or 
biopsy for definitive diagnosis. 
The recommended dose of prednisone is 60 mg in adults and 1–2.5 
mg/kg/day in children; dexamethasone is 8–16 mg/day in both adults and 
children for 3–6 weeks, tapered over 2–4 weeks . 
 
 
SURGERY: 
 Surgical intervention is reserved for patients with significant raised 
intracranial pressure, impending visual failure, hydrocephalus, or those in 
whom paradoxical increase in size is noted during treatment . 
          Surgical decompression or excision is often required in large 
masses which cause significant increased intracranial pressure or 
impending loss of vision. A CSF diversion procedure may be performed 
in cases of obstructive hydrocephalus caused by tuberculomas. (10,22,26)   
 
PROGNOSIS : 
 Rajeswari et al.  reported that 88% of intracranial “tuberculomas” 
had resolved at the end of 9 months of ATT and repeat imaging 
performed 15 months later demonstrated resolution of 80% of lesions. A 
study by Wanget al.  demonstrated that 80% of intracranial tuberculomas 
had resolved by the end of 6 months of ATT. In a recent study by Awada 
et al. , complete resolution of intracranial tuberculomas was noted for all 
18 patients within 12 months after initiation of ATT . Those authors 
suggested that a longtreatment regimen (15–18 mo) might not be 
necessary for intracranial tuberculomas occurring among 
nonimmunocompromised patients. However, all of the studies cited 
above and in  suffer from the lack of clear criteria for the diagnosis of 
tuberculomas. The diagnoses were based almost entirely on radiological 
criteria and not on histopathological studies.  The presence of coma and 
 delay in instituting ATT for more than 3 days would have poor outcome . 
Delays in treatment may be due to lack of a multi-pronged diagnostic 
approach, a lack of characteristic CSF parameters, and no evidence of 
previous exposure to TB. Other prognostic factors correlating with poor 
performance to ATT are age (children <3 years and adults >50 years of 
age)  and co-existence of miliary TB. Other CSF parameters that are 
associated with poor prognosis are decreased glucose level and a 
markedly elevated protein level. None of these have an established 
predictor value of mortality . Nearly 20–25% of survivors manifest a 
variety of neurological sequelae. (39,42,16)   
 
 
 
  
MATERIALS AND METHODS 
SETTING 
 The study was conducted on the  inpatients of the Institute of 
Internal Medicine and Department of Neurology, Madras Medical 
College and Government General Hospital, Chennai. 
 COLLABORATION DEPARTMENTS 
Institute of Internal Medicine 
Department of Neurology 
Department of Microbiology 
ETHICAL APPROVAL 
 Institute Ethical Committee approved the study 
STUDY DESIGN 
 Single Center 
 Non randomized cross sectional study 
STUDY PERIOD 
 Study was conducted between September 2005 and September 
2007 for a period of 2 years. 
SAMPLE SIZE 
 In the study period of 2 years among the patients with brain 
granuloma, attending the Institute of Internal Medicine and Dept of 
 Neurology, after applying inclusion and exclusion criteria 43 patients 
were included in this study. 
SELECTION OF STUDY SUBJECTS 
 Newly  detected  patients  with  solitary  brain  granuloma  
attending the  Medicine  and  Neurology department during  the  study  
period.  
 
INCLUSION CRITERIA 
1. All newly detected   patients who have granulomatous lesions in 
the brain, detected by C.T.Scan. 
 
2. The patients should have no other neurological problems and 
should not be on any medications previously.. 
 
EXCLUSION CRITERIA 
      1. Patients who have neurological problems other than due to   
granulomatous lesions, of the brain. 
      2. More or equal to   two  lesions in C.T.Brain. 
      3. Patients who are less than 12 years of age and over 60 years of age 
 4. Pregnant women. 
CONSENT 
 All participants gave written informed consent 
 METHODOLOGY    
A detailed history was obtained  from the patients with relevant to brain 
granuloma .Past history of tuberculosis and  history of  contact with 
tuberculous patient were obtained. A thorough clinical examination was 
performed at the time of admission and relevant findings were  recorded. 
CT brain plain and contrast study were done in all patients in the study 
group. MRI brain was done when indicated .The solitary ring enhancing 
lesions were categorized as tuberculoma and neurocysticercosis 
according to the Rajasekar’s criteria.Lumbar puncture and CSF analysis 
was done for TB-PCR and EIA(Enzyme ImmunoAssay) for cysticeral 
antigen in  all patients in the study group. Earliest possible EEG was 
attempted and was performed using 32 channel digital EEG recorder.  
        In view of tuberculoma,    Mantoux testing and Chest X ray 
were performed in all cases in the study group.     Clinical data was 
collected from patients and witnesses in a systematic manner and added 
to a database, which included a checklist of  the symptoms associated 
with brain granuloma.The results of the investigation and 
symptomatology were stastically analysed.  
STASTISCAL ANALYSIS 
  SPSS 12 and Excel were used for data analysis 
LIMITATIONS   
  Small number  of study subjects. Lack of Brain biopsy of the 
granulomatous lesion. 
CONFLICT OF INTEREST :  Nil conflict of interest 
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RESULTS AND OBSERVATIONS 
 
POPULATION CHARACTERISTICS 
 Among the 43 patients included in this study, 23 patients were men 
accounting for 54% of the total cases. The remaining 20 patients were 
women (46%). 
TABLE 1 : SEX DISTIBUTION OF THE STUDY 
SEX NO.OF PATIENTS PERCENTAGE 
MALE 23 54% 
FEMALE 20 46% 
                                                                                                              p>0.05 
 According to the age, patients’ aged below  20 years were 12 in 
number (28%). Majority of the patients were in the age group between 21 
and 30 years - 15 patients (35% of study population) were in this group. 
Only 9 patients (21%) were between the age of 31 and 40 years. And 7 
patients (16%) were above the age of 40. Population characteristics are 
shown in table 2. 
TABLE 2 : POPULATION DISTRIBUTION 
AGE GROUP 
(in years) 
NO. OF PATIENTS PERCENTAGE 
<20 12 28% 
 21-30 15 35% 
31-40 9 21% 
>40 7 16% 
                                                                                             p>0.05 
 
In our study, the most common presentation is seizure. Fourty  
patients had seizures at the time of presentation, forming 93% of the total 
patients. Only  5% of  patients had head ache as the initial complaint .And  
1 % patient had focal deficit.   
 
 Nearly  53% of patients had generalize tonic clonic seizures as the 
initial complaint. Secondary generalized tonic clonic seizures  were seen 
in  21% of the total patients. Complex partial seizures and simple partial 
seizures are seen in 7%  and  12 %  of the patients respectively. 
 
 
 
 
TABLE 3 : PRESENTATION IN OUR STUDY 
PRESENTATION 
 
NO.OF PATIENTS PERCENTAGE 
 GENERALIZED                  
SEIZURES 
23 53% 
SECONDARY 
GENERALIZED 
SEIZURES 
9 21% 
COMPLEX  PARTIAL 
SEIZURES 
3 7% 
SIMPLE PARTIAL 
SEIZURES 
5 12% 
HEAD ACHE 2 5% 
FOCAL DEFICIT 1 2% 
                                                                            p>0.05 
Base upon the  criteria described by Rajasekar et al  and other 
supportive evidences, the granulomas are differentiated into tuberculoma 
and neurocysticercosis. Thirty one patients(72%) are found to have 
neurocysticercosis and twelve patients (28%) had tuberculoma. 
 
TABLE 4 : TYPE OF BRAIN GRANULOMA  
            TYPE NO. OF PATIENTS PERCENTAGE 
NEUROCYSTICERCOSIS              31             72% 
TUBERCULOMA              12             28% 
                                                                             p>0.05 
 
Majority of Neurocysticercosis were found in third decade of life 
(39%).Age groups less than 20 years and 31-40 formed 29% and 27% 
respectively. Only  10%  of patients with neurocysticercosis were above 
40 years of age group.Most of Tubberculoma patients were above forty 
years (33%).Age group less than 20 years and 21 – 30 constituted   25 % 
of patients with Tuberculoma. Only 17% of patients with Tuberculoma 
were within 21 – 30 years age group. 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1: AGE DISTRIBUTION  
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In this study ,  61% of  patients with Neurocysticercosis most often 
presented with generalized tonic clonic seizures. And 16% of patients 
presented with secondary generalized seizures .Only 3 % of  patient with 
neurocysticercosis had head ache as the chief complaint. Simple partial 
seizures and Complex partial seizures accounts for 13% and 7 % of 
patient with neurocysticercosis. 
 
 
 
Generalized tonic clonic seizures and secondary seizures are 
equally seen in patients with tuberculoma , about 4 patients each  
 (34%).Simple partial seizures , complex partial seizures ,focal deficit and  
head ache constituted  8 % of patient each with tuberculoma. 
TABLE 5 :CLINICAL PRESENTATION IN BRAIN 
GRANULOMA  
PRESENTATION NEUROCYSTICERCOSIS TUBERCULOMA 
GENERALIZED 
SEIZURES 
19(61%) 4(34%) 
SECONDARY 
GENERALIZED 
SEIZURES 
5(16%) 4(34%) 
COMPLEX 
PARTIAL 
SEIZURES 
2(7%) 1(8%) 
SIMPLE  PARTIAL 
SEIZURES 
4(13%) 1(8%) 
HEAD ACHE 1(3%) 1(8%) 
FOCAL DEFICIT 0 1(8%) 
                                                                                    p>0.05 
 
 
 Most of the lesions were found in Parietal region (58%).About 
14% patients had lesion in the Temporal region. Frontal lobe granuloma 
are seen in 16% of  patients.Only 12 % of patients had brain granuloma in 
the Occipital region . 
FIGURE 2 : LOCALISTION OF BRAIN GRANULOMA 
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TABLE 6 : SITE OF BRAIN GRANULOMA  
SITE OF BRAIN 
GRANULOMA 
NO. OF PATIENTS  PERCENTAGE 
  PARIETAL                25                58% 
  TEMPORAL                  6                14% 
  FRONTAL                  7                16% 
 OCCIPITAL                  5                12% 
                                                                                     p>0.05 
  
In our study ,most of the neurocysticercosis were found in Parietal 
lobe(55%).Temporal lobe , Frontal lobe and Occipital lobe accounted for 
13% , 19% and 13% respectively. 
 
Tuberculoma   were mostly seen in the Parietal region(67%).Only 
67% of  patients had the lesion over the Temporal region. Tuberculoma 
were seen in frontal and occipital region in 8 % of  patient .  
 
 
 
  
 
TABLE 7 : LOCALISATION OF BRAIN GRANULOMA 
SITE OF BRAIN 
GRANULOMA 
NEUROCYSTICERCOSIS TUBERCULOMA 
PARIETAL            17 (55%)             8(67%) 
TEMPORAL              4(13%)             2(17%) 
FRONTAL              6(20%)             1(8%) 
OCCIPITAL              4(13%)             1(8%) 
                                                                                              p>0.05 
 
Electroencephalogram (EEG) was found to be normal in 18 
patients(42%) in our study. Diffuse slowing was noted in 37% of patient. 
Focal spikes formed 21% of the patients. 
TABLE8 : EEG FINDINGS IN OUR STUDY  
EEG  PATTERN NO. OF PATIENTS  PERCENTAGE 
NORMAL                 18             42% 
FOCAL SPIKES                 16             37% 
SLOW  WAVES                  9             21% 
                                                                                      p>0.05 
 
 FIGURE 3 : EEG PATTERN IN BRAIN GRANULOMA 
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EEG findings showed focal spikes in 42% and 25 % of patients 
with Neurocysticercosis and Tuberculoma respectively. About 58% of 
patients with tuberculoma had Normal EEG pattern. Diffuse Slow waves 
are seen in 23% and 17% of the patients with Neurocysticercosis and 
Tuberculoma.  
TABLE 9 : EEG PATTERN IN BRAIN GRANULOMA  
TYPE OF BRAIN 
GRANULOMA 
 
    NORMAL 
FOCAL 
SPIKES 
SLOW 
WAVES 
NEUROCYSTICERCOSIS 11(36%) 13(42%) 7(23%) 
TUBERCULOMA 7(58%) 3(25%) 2(17%) 
                                                                                p> 0.05 
 
  
In this study,Enzyme ImmunoAssay (EIA) of cysticercal antigen 
was positive in  81% of  patients with neurocysticercosis. 
TABLE 10: ENZYME IMMUNO ASSAY IN 
NEUROCYSTICERCOSIS 
             EIA POSITIVE NEGATIVE 
NEUROCYSTICERCOSIS 25(81%) 6(19%) 
                                                                                       P<0.05 
 
Tb- PCR showed 42% positivity in patients with  Tuberculoma. Chest X 
Ray showed Upper Zone Infiltrates in 25% of  cases with Tuberculoma . 
And Mantoux was positive in 25% of  patients with Tuberculoma. 
 
TABLE 11: SUPPORTIVE INVESTIGATION IN 
TUBERCULOMA  
    INVESTIGATIONS              POSITIVE          NEGATIVE 
        CHEST X RAY               3(25%)                 9(75%) 
          MANTOUX               3(25%)                 9(75%) 
            TB-PCR               5(42%)                 7(58%) 
                                                                                                     P > 0.05 
 
  
 
 
Discussion 
  
 
 
  DISCUSSION 
Brain granuloma continues to be the most common cause 
of seizures in young people in the developing world. It 
continues to be a considerable cause of  morbidity and mortality  
affecting both males and females . Despite its high frequency, 
the precise incidence and prevalence of NCC and Tuberculoma 
were difficult to obtain due to different factors, such as the high 
number of asymptomatic  infections, the pleomorphism of 
clinical manifestations, the lack of a reliable test for serological 
screening, and the necessary use of expensive neuroimaging 
studies for diagnosis and therapeutic decisions. 
 In this study ,  male  to female ratio is  1.2 : 1 which is 
similar to other studies  of Antônio de Souza et al where 53% of 
patients were males and 47% of patients were female and  
M.Gupta et al, a study on solitary brain granuloma where the 
male to female ratio was 1.3 to 1. 
 Most of the patients with brain granuloma were from  20 
to 30 years of age  (35%). And 63% of the patients were less 
than 30 years of age group.  The Mean Age of presentation was 
29.4 years, again it proves that the disease primarily affects the 
working population .This is similar to other studies of  Antonio 
et al, Praphan et al and Kuruvilla et al. Majority of Tuberculoma 
were seen in greater than 40 years of Age (33%) .But 
Neurocysticercosis were seen in commonly in lessthan 30 years 
of age (68%). 
FIGURE 4 :MEAN AGE OF PRESENTATION 
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 About 93% of the patients in the present study , came with 
seizures similar to most of the  other studies. Most studies have 
describes seizures as the most common presentation.In this 
study , most common presentation was generalised tonic clonic 
seizures. But other studies have quoted partial seizures as a 
common presentation. This may be because  the seizure typing 
in this study was entirely made on history. The grey area in 
relying on history in classification of seizures is in the fact that 
the focal onset of a seizure is often missed and witnesses' 
attention is often drawn to the person only after an event 
becomes generalized. Secondly, this study included lesser 
number of patients . 
According to a study done in Brazil, the proportion of  
patients with seizures was less common compared to the present 
study. In Antonio de souza et al, around 81% had seizures ,12% 
of the patients had head ache and 7 % of them had focal deficit. 
 
 In another study by Carpio et al, about 71% of patients had 
seizures. About 21% and 7% of the patients had head ache and 
focal abnormalities respectively.  
FIGURE 5 :CLINICAL PRESENTATION IN VARIOUS 
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In this study ,about 84% of patients with 
neurocysticercosis presented with seizures similar to the  study 
by A Kuruvilla et al showing that nearly 90% of patient had  
seizures. There was no patient with neurocysticercosis who had 
focal deficit in this study.On contrary , nine percent of patients 
 had focal deficit in Kuruvilla et al.The prevalence of head ache 
was comparable in both the studies. 
FIGURE 6 :PRESENTATION IN NEUROCYSTICERCOSIS 
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PRESENTATION IN TUBERCULOMA: 
 In a study done by Teoh et al the proportion of patients 
with focal deficit and head ache were more common compared 
to this study. Seizure was more common in the present study 
accounting for 84% of the patients. 
 
 FIGURE 7 : PRESENTATION IN TUBERCULOMA 
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SITE OF BRAIN GRANULOMA IN VARIOUS 
STUDIES 
This study showed that parietal region was the most common 
site of brain granuloma accounting for 58%.Temporal,Frontal 
and Occipital regions had 14%,16% and 12% of the brain 
granulomas.  
This pattern of distribution of brain granuloma is similar to other 
studies (Maneesh et al and Shri ram et al).But a study by 
 Prophan et al showed Frontal lobe granuloma to be more 
common than Parietal lobe granuloma. 
FIGURE 9 : LOCALISATION OF BRAIN GRANULOMA 
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There was no correlation between EEG findings and the 
type of brain granuloma . Present study also showed that there 
was no correlation between the site of granuloma and the type of 
seizures. Majority of the patients had normal findings in EEG 
comparable to  other studies. 
 In a study by Maneesh et al nearly 76% of patients had 
normal EEG findings .Nineteen percent of individuals had slow 
waves in EEG .Only 5% of patients had focal Spikes. 
In a study by Kuruvilla et al, 71% had normal EEG 
findings and 29% of them had a slow wave pattern.  
FIGURE 8 : EEG PATTERN IN VARIOUS STUDIES 
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TB-PCR was sensitive in 42% of patients with tuberculoma in our 
study. According to  Muralidhar K. Katti et al the sensitivity for TB-PCR 
was 48% in patients with Tuberculoma. 
 In this study, the chest X ray and Mantoux was positive in 25% of 
patients with Tuberculoma. Christian Pagnoux et al the chest x ray was 
positive in 25 to 83% of patients with Tuberculoma. He reported the 
positive Mantoux was seen in 25 to 75% of patients with Tuberculoma 
The Enzyme Immunoassay(EIA) for cysticercal antigen  was 
positive in 81% of patients with Neurocysticercosis in our study. 
Alessandra  Xavier Pardini et al showed that  EIA for cysticeral antigen 
was positive in 82 to 96% of individuals with Neurocysticercosis.  
 
 
 
 
 
  
 
 
    
 
 
Conclusions 
 
 
 
  
 
 
 
CONCLUSIONS 
1. There was No sex Predilection seen in patients with Brain 
Granuloma. 
2. In this study population, Neurocysticercosis formed the Most 
common cause of Brain Granuloma  . 
      3. The Mean  Age of presentation of Brain Granuloma was 29.4 years 
4. Most patients with Neurocysticercosis were in the Third decade of 
life 
5. Most patients with Tuberculoma were Above Forty years of age. 
6. In this study , Most Common Presentation was  Generalized Tonic 
Clonic Seizures. 
7. In this study , about 97% of patients with Neurocysticercosis 
presented with seizures. 
8. Seizure was seen in  84% of the patients with Tuberculoma. 
9. This study showed that Parietal region was the Most Common  Site 
of brain granuloma accounting for 58%. 
 10. There was No correlation between EEG findings and the Type Of 
Brain Granuloma. 
11. TB-PCR was sensitive in 42% of patients with tuberculoma in our 
study. 
12. In this study, the chest X ray  was positive in 25% of patients with 
Tuberculoma. 
13. Mantoux was positive in 25% of patients with Tuberculoma. 
14. The Enzyme Immunoassay(EIA) for cysticercal antigen  was 
positive in 81% of patients with Neurocysticercosis . 
 
 
 
 
 
 
 
 
  
 
 
Summary
 SUMMARY 
• Brain Granuloma  Must be ruled out in all cases presenting 
with  new onset seizures among young individuals. 
• Neurocysticercosis was the most common cause of brain 
granuloma. 
• Tuberculoma was prevalent among Older people whereas 
Neurocysticerrcosis  was prevalent among Young 
individuals. 
• Most common presentation among Brain granuloma 
patients was  Generalized tonic clonic seizures. 
• Electroencephalogram had No correlation with the Type  of 
Brain Granuloma. 
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Master Chart    
 S.No Name Age Sex Presenting Complaint CT/MRI 
Type of 
Lesion EEG EIA TBPCR 
Chest X-
Ray 
Man 
Toux 
1 
Divyalakshmi 
19 F Generalised tonic clonic 
seizures 
Left Parietal Ring Enhancing 
Lesion Tuberculoma Normal  Negative Negative Normal Negative 
2 
Subburaj 
38 M Generalised tonic clonic 
seizures 
Left Frontal Ring Enhancing 
Lesion Neurocysticercosis 
Slow Delta 
Waves Positive Negative Normal Negative 
3 
Vasantha 
25 F 
Simple partial seizures 
Right Fronto Parietal Ring 
Enhancing Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
4 
Dhanalakshmi 
13 F 
Secondary GTCS 
Right Dorsolateral  Frontal 
Ring Enhancing Lesion Tuberculoma Normal  Negative Positive 
Upper Zone 
Infiltrates + Positive 
5 
Venkatesh 
37 M 
Headache Left Parietal Calcification Neurocysticercosis 
Slow Delta 
Waves Positive Negative Normal Negative 
6 
Pradeep 
20 M Generalised tonic clonic 
seizures 
Left Posterior Parietal Ring 
Enhancing Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
7 
Kalaivanan 
17 M Generalised tonic clonic 
seizures 
Right Tempero Parietal Ring 
Enhancing Lesion Tuberculoma Normal  Negative Negative Normal Negative 
8 
Durai Kannu 
28 M 
Simple partial seizures 
Left Fronto Parietal Ring 
Enhancing Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
9 
Ramya 
26 F Generalised tonic clonic 
seizures 
Right Occipital Ring 
Enhancing Lesion Neurocysticercosis Normal  Positive Negative Normal Negative 
10 
Muthu 
29 M 
Secondary GTCS 
Right High Parietal Ring 
Enhancing Lesion Neurocysticercosis Normal  Positive Negative Normal Negative 
11 
Shivamani 
42 F 
Complex partial seizures Left Temporal Calcification Neurocysticercosis 
Slow Delta 
Waves Negative Negative Normal Negative 
12 
Rani 
37 F 
Left side hemiparesis 
Right Tempero Parietal Ring 
Enhancing Lesion Tuberculoma 
Focal 
Spikes Negative Negative 
Upper Zone 
Infiltrates + Positive 
13 
Durga 
18 F Generalised tonic clonic 
seizures Right Parietal Calcification Neurocysticercosis Normal  Positive Negative Normal Negative 
14 
Mari 
44 M 
Secondary GTCS 
Right Temporal Ring 
Enhancing Lesion Tuberculoma 
Slow Delta 
Waves Negative Negative Normal Negative 
15 
Kannan 
36 M Generalised tonic clonic 
seizures 
Multiple Ring Enhancing 
Lesion Neurocysticercosis 
Slow Delta 
Waves Positive Negative Normal Negative 
 S.No 
Name 
Age Sex Presenting 
Complaint CT/MRI  
Type of 
Lesion EEG EIA TBPCR 
Chest X-
Ray  
Man 
Toux 
16 Mohammed 
Fakrudin 
38 M Generalised tonic clonic 
seizures 
Left Frontal Ring Enhancing 
Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
17 
Suresh 
28 M 
Simple partial seizures 
Left Parietal Ring Enhancing 
Lesion Tuberculoma Normal  Negative Negative Normal Negative 
18 
Krishnasami 
29 M Generalised tonic clonic 
seizures 
Right Tempero Parietal Ring 
Enhancing Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
19 
Stella 
24 F Generalised tonic clonic 
seizures 
Left Parietal Ring Enhancing 
Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
20 
Manickam 
42 M 
Secondary GTCS 
Left Occipital Ring Enhancing 
Lesion Tuberculoma 
Focal 
Spikes Negative Negative Normal Negative 
21 
Karthik 
22 M Generalised tonic clonic 
seizures 
Right Frontal Ring Enhancing 
Lesion Neurocysticercosis Normal  Negative Negative Normal Negative 
22 
Muthu 
19 M Generalised tonic clonic 
seizures Right Parietal Calcification  Neurocysticercosis 
Slow Delta 
Waves Positive Negative Normal Negative 
23 
Lakshmi 
36 F 
Complex partial seizures 
Left Parietal Ring Enhancing 
Lesion Tuberculoma 
Focal 
Spikes Negative Positive Normal Negative 
24 
Gomathi 
16 F 
Secondary GTCS 
Left Parietal Ring Enhancing 
Lesion Neurocysticercosis 
Slow Delta 
Waves Positive Negative Normal Negative 
25 
Shankar 
35 M Generalised tonic clonic 
seizures Right Frontal Calcification Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
26 
Maragatham 
24 F Generalised tonic clonic 
seizures 
Left Tempero Parietal Ring 
Enhancing Lesion Tuberculoma Normal  Negative Negative Normal Positive 
27 
Sushila 
21 F Generalised tonic clonic 
seizures 
Right Frontal Ring Enhancing 
Lesion Neurocysticercosis 
Slow Delta 
Waves Positive Negative Normal Negative 
28 
Kanniammal 
51 F 
Headache 
Left Parietal Ring Enhancing 
Lesion Tuberculoma Normal  Negative Positive 
Upper Zone 
Infiltrates + Negative 
29 
Anandan 
22 M 
Secondary GTCS 
Left Temporal Ring Enhancing 
Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
30 
Nithya 
27 F Generalised tonic clonic 
seizures Right Parietal Calcification Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
 S.No 
Name 
Age Sex Presenting 
Complaint CT/MRI  
Type of 
Lesion EEG EIA TBPCR 
Chest X-
Ray  
Man 
Toux 
31 
Murugan 
19 M Generalised tonic clonic 
seizures 
Multiple Ring Enhancing 
Lesion Neurocysticercosis 
Slow Delta 
Waves Negative Negative Normal Negative 
32 
Shanthi 
44 F 
Complex partial seizures 
Left Parietal Ring Enhancing 
Lesion Neurocysticercosis Normal  Negative Negative Normal Negative 
33 
Mala 
20 F Generalised tonic clonic 
seizures 
Left Frontal Ring Enhancing 
Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
34 
Rizwan 
32 M 
Secondary GTCS 
Right Occipital Ring 
Enhancing Lesion Neurocysticercosis 
Slow Delta 
Waves Negative Negative Normal Negative 
35 
Chelladurai 
29 M Generalised tonic clonic 
seizures 
Right Temporal Ring 
Enhancing Lesion Neurocysticercosis Normal  Positive Negative Normal Negative 
36 
Deepa 
13 F 
Simple partial seizures Left Parietal Calcification Neurocysticercosis Normal  Positive Negative Normal Negative 
37 
Kandasami 
37 M 
Simple partial seizures 
Left Temporal Ring Enhancing 
Lesion Neurocysticercosis Normal  Negative Negative Normal Negative 
38 
Ravi 
16 M Generalised tonic clonic 
seizures 
Right Tempero Parietal 
Calcification Neurocysticercosis 
Slow Delta 
Waves Positive Negative Normal Negative 
39 
Swarnam 
20 F Generalised tonic clonic 
seizures 
Right Parietal Ring 
Enhanching Lesion Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
40 
Maheshwari 
24 F 
Secondary GTCS 
Left Parietal Ring Enhancing 
Lesion Tuberculoma 
Slow Delta 
Waves Negative Positive Normal Negative 
41 
Kamakshi 
53 F Generalised tonic clonic 
seizures Right Parietal Calcification  Neurocysticercosis 
Focal 
Spikes Positive Negative Normal Negative 
42 
Ponnusamy 
28 M 
Secondary GTCS 
Right Parietal Ring 
Enhanching Lesion Neurocysticercosis 
Slow Delta 
Waves Positive Negative Normal Negative 
43 
Govindraj 
65 M Generalised tonic clonic 
seizures 
Left Temporal Ring Enhancing 
Lesion Tuberculoma Normal  Negative Positive Normal Negative 
 
 
 
